G protein-coupled receptors: Abnormalities in signal transmission, disease states and pharmacotherapy

Acta Poloniae Pharmaceutica - Drug Research

Volumn 71, Issue 2, 2014, Pages 229-243

  Zalewska, Marta ^a   Siara, Monika ^a   Sajewicz, Waldemar ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

G protein coupled receptor; Pharmacotherapy

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; ARGIPRESSIN RECEPTOR; BETA ADRENERGIC RECEPTOR; CALCIUM ION; CALCIUM SENSORING RECEPTOR; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HORMONE RECEPTOR; LIGAND; MELANOCORTIN 4 RECEPTOR; NEUROTRANSMITTER RECEPTOR; PEPTIDOLEUKOTRIENE; RHODOPSIN; UNCLASSIFIED DRUG;

ASTHMA; BARDET BIEDL SYNDROME; CELL COMMUNICATION; CELL TRANSPORT; DISEASE COURSE; GENE FUNCTION; GENE MUTATION; GENE STRUCTURE; HEART FAILURE; HUMAN; HUMAN GENOME; LIGAND BINDING; MOLECULAR PATHOLOGY; NEPHROGENIC DIABETES INSIPIDUS; NEUROTRANSMISSION; OBESITY; PHARMACEUTICAL CARE; PHOTON; PHYSIOLOGICAL PROCESS; RETINITIS PIGMENTOSA; REVIEW; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION; USHER SYNDROME;

ANIMALS; DRUG THERAPY; HUMANS; LIGANDS; MOLECULAR TARGETED THERAPY; MUTATION; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84897416853     PISSN: 00016837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Rosenbaum D.M., Rasmussen S.G.F., Kobilka B.K.: Nature 459, 356 (2009).
2. Pierce K.L., Premont R.T., Lefkowitz R.J.: Mol. Cell Biol. 3, 639 (2002).
3. Latek D, Pasznik P, Carlomagno T, Filipek S.: PLoS One 8, e56742. (2013).
4. Thompson M.D., Burnham W.M., Cole D.E.C.: Crit. Rev. Clin. Lab. Sci. 42, 311 (2005).
5. Alexander S.P.H., Mathie A., Peters J.A.: Br. J. Pharmacol. 164, 1 (2011).
6. Jacoby E., Bouhelal R., Gerspacher M., Seuwen K.: Chem. Med. Chem. 1, 760 (2006).
7. Millar R.P., Newton C.L.: Mol. Endocrinol. 24, 261 (2010).
8. Foord S.M., Bonner T.I., Neubig R.R., Rosser E. M., Pin J., Davenport A. P., Spedding M., Harmar A.J.: Pharmacol. Rev. 57, 279 (2005).
9. Sharman J.L., Mpamhanga C.P., Spedding M., Germain P., Staels B., Dacquet C., Laudet V., Harmar A.J.: Nucl. Acids Res. 39, 534 (2011).
10. Oldham W.M., Hamm H.E.: Nat. Rev. Mol. Cell Biol. 9, 60 (2008).
11. Tuteja N.: Plant. Sign. Beh. 4, 942 (2009).
12. Lodowski D.T., Tesmer V.M., Benovic J.L., Tesmer J.J.G.: J. Biol. Chem. 281, 16785 (2006).
13. Kobilka B.K., Xavier Deupi X.: Trends Pharmacol. Sci. 28, 397 (2007).
14. Insel P.A., Tang C., Hahntow I., Miche M.C.: Biochim. Biophys. Acta 1768, 994 (2007).
15. Scḧneberg T., Schulz A., Biebermann H., Hermsdorf T., Römpler H., Sangkuhl K.: Pharmacol. Therap. 104, 173 (2004).
16. Morris M.B., Dastmalchi S., Church B.W.: Int. J. Biochem. Cell Biol. 41, 721 (2009).
17. Tao Y.: Pharmacol. Therap. 120, 129 (2008).
18. Hartong D.T., Berson E.L., Dryja T.P.: Lancet 368, 1795 (2006).
19. Nakazawa M.: J. Ophthalmol. 2011, 292040, (2011).
20. Cervia D., Casini G.: World J. Pharmacol. 1, 30 (2012).
21. Dryja T.P.: Am. J. Ophthalmol. 130, 547 (2000).
22. Brodde O.: Pharmacol. Therap. 117, 1 (2008).
23. Thomsen M., Dahl M., Tybjærg-Hansen A., Nordestgaard B.G.: J. Intern. Med. 271, 305 (2011).
24. Bernstein D., Fajardo G., Zhao M., Urashima T., Powers J., Berry G., Kobilka B.K.: Am. J. Physiol. Heart Circ. Physiol. 289, H2441 (2005).
25. Tao YX.: Endocr. Rev. 31, 506 (2010).
26. Govaerts C., Srinivasan S., Shapiro A., Zhang S., Picard F., Clement K., Lubrano-Berthelier C., Vaisse C.: Peptides 26, 1909 (2005).
27. Srinivasan S., Lubrano-Berthelier C., Govaerts C., Picard F., Santiago P., Conklin B. R., Vaisse C.: J. Clin. Invest. 114, 1158 (2004).
28. BMI classification. Global Database on Body Mass Index. WHO. (2006). Retrieved May 12, 2013.
29. Sanderson S.C., Diefenbach M.A., Streicher S.A., Jabs E.W., Smirnoff M., Horowitz C.R., Zinberg R. et al.: Public Health Genomics 16, 83 (2013).
30. Stein Q.P., Mroch A.R., De Berg KL, Flanagan J.D.: S D Med. 12, 17 (2011).
31. Spankis E., Milord E., Gragnoli C.: J. Cell Physiol. 217, 605 (2008).
32. Sands J.M., Bichet D.G.: Ann. Intern. Med. 144, 186 (2006).
33. Los E.L ., Deen P.M.T., Robben J.H.: J. Neuroendocrinol. 22, 393 (2010).
34. Wesche D., Deen P.M.T., Knoers N.V.A.M.: Pediatr. Nephrol. 8, 1 (2012).
35. Ulloa-Aguirre A., Conn P.M.: Recent Pat. Endocr. Metab. Immune Drug Discov. 5, 13 (2011).
36. Brown E.M., Egbuna O.I.: Best Pract. Res. Clin. Rheumatol. 22, 129 (2008).
37. Rasmussen A.Q., Jørgensen N.R., Schwarz P.: J. Med. Case Rep. 564, 1 (2011).
38. Bisgaard H.: Allergy 56, 7 (2001).
39. Capra V., Thompson M.D., Sala A., Cole D.E., Folco G., Rovati E. G.: Med. Res. Rev. 27, 469 (2007).
40. Singh R. K., Gupta S., Dastidar S., Ray A.: Pharmacology 85, 336 (2010).
41. Tse S.M., Tantisira K., Weiss S.T.: Pharmacogenomics J. 11, 383 (2011).
42. Shintani K., Shechtman D.L., Gurwood A.S.: Optometry 80, 384 (2009).
43. Gerthoffer W.T., Solway J., Camoretti-Mercado B.: Curr. Opin. Pharmacol. 13, 342 (2013).